Investigation of a New Compression Bandage System Combining Skin Protection, Padding and Compression in One Single Bandage and Comparing to an Existing One-component Bandage.

Inclusion Criteria:

• Healthy intact skin with no clinical signs of chronic venous insufficiency and nosigns of any dermatological condition such as eczema or psoriasis as assessed byinvestigating physician.

• Ankle circumference > 18 cm (2 cm above ankle) as assessed by the investigatingphysician.

Exclusion Criteria:

• Known sensitivity to the study products (Rosidal 1C or Urgo K1) or any of theircomponents

• Chronic venous disease with CEAP ≥2

• Ankle Brachial Pressure Index (ABPI) < 0.8 or >1.3

• Ankle circumference <18 or > 32 cm

• Venous echo-Doppler with recognizable abnormalities

• History of

• malignant ulcer

• clinically infected wound

• peripheral arterial occlusive diseases,

• cardiac insufficiency or cardiac disease such as congestive heart failure,coronary artery disease, myocardial infarction, coronary artery bypass graft

• cerebrovascular disease

• liver or renal disease

• septic phlebitis,

• phlegmasia coerulea dolens,

• sensation disorders of the skin

• eczema, psoriasis

• Use of diuretics, antihypertension or drugs that influence the capillaryinfiltration

• Comorbidities that could affect compression therapy, particularly diseases causingoedema

• Reliable severe malnutrition

• Diabetes Mellitus

• BMI > 30 kg/m2

• Pregnancy or breast feeding

• Participation in an interventional clinical trial within the last 3 months andduring participation in this study

• Participant is analphabet